Collegium Pharmaceutical, Inc. Increase (Decrease) in Accrued Liabilities
Collegium Pharmaceutical, Inc. (COLL) reported Increase (Decrease) in Accrued Liabilities of $8.12 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-06
- Collegium Pharmaceutical, Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was $12.28M, a 119.71% increase year-over-year.
- Collegium Pharmaceutical, Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was -$4.15M.
- Collegium Pharmaceutical, Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was $10.71M, a 52.26% decline year-over-year.
- Collegium Pharmaceutical, Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was -$8.11M.
- Collegium Pharmaceutical, Inc. increase (decrease) in accrued liabilities for fiscal 2025 was -$9.49M.
- Collegium Pharmaceutical, Inc. increase (decrease) in accrued liabilities for fiscal 2024 was -$39.53M, a 6394.59% decline from fiscal 2023.
- Collegium Pharmaceutical, Inc. increase (decrease) in accrued liabilities for fiscal 2023 was $628.00K.
- Collegium Pharmaceutical, Inc. increase (decrease) in accrued liabilities for fiscal 2022 was -$11.13M, a 333.01% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $12.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $8.12M 10-Q · filed 2026-08-06 | $18.83M derived: sum of 3 quarters · filed 2026-08-06 | $10.71M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$4.15M 10-Q · filed 2026-05-07 | $6.55M derived: sum of 2 quarters · filed 2026-05-07 | -$1.56M derived: sum of 3 quarters · filed 2026-05-07 | $4.03M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $10.71M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.59M derived: sum of 2 quarters · filed 2026-02-26 | $8.18M derived: sum of 3 quarters · filed 2026-08-06 | -$9.49M 10-K · filed 2026-02-26 |
| 2025-09-30 | -$8.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$2.53M derived: sum of 2 quarters · filed 2026-08-06 | -$20.20M 10-Q · filed 2025-11-06 | $2.22M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $5.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$12.09M 10-Q · filed 2026-08-06 | $10.34M derived: sum of 3 quarters · filed 2026-08-06 | -$52.60M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$17.67M 10-Q · filed 2026-05-07 | $4.75M derived: sum of 2 quarters · filed 2026-05-07 | -$58.19M derived: sum of 3 quarters · filed 2026-05-07 | -$57.86M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $22.42M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$40.51M derived: sum of 2 quarters · filed 2026-02-26 | -$40.19M derived: sum of 3 quarters · filed 2026-02-26 | -$39.53M 10-K · filed 2026-02-26 |
| 2024-09-30 | -$62.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$62.61M derived: sum of 2 quarters · filed 2025-11-06 | -$61.95M 10-Q · filed 2025-11-06 | -$56.84M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $322.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $982.00K 10-Q · filed 2025-08-07 | $6.09M derived: sum of 3 quarters · filed 2026-02-26 | $2.49M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $660.00K 10-Q · filed 2025-05-08 | $5.77M derived: sum of 2 quarters · filed 2026-02-26 | $2.17M derived: sum of 3 quarters · filed 2026-02-26 | $13.42M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $5.11M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.51M derived: sum of 2 quarters · filed 2026-02-26 | $12.76M derived: sum of 3 quarters · filed 2026-02-26 | $628.00K 10-K · filed 2026-02-26 |
| 2023-09-30 | -$3.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $7.65M derived: sum of 2 quarters · filed 2024-11-07 | -$4.48M 10-Q · filed 2024-11-07 | $9.11M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $11.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$884.00K 10-Q · filed 2024-08-08 | $12.70M derived: sum of 3 quarters · filed 2025-02-27 | -$4.36M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | -$12.13M 10-Q · filed 2024-05-09 | $1.46M derived: sum of 2 quarters · filed 2025-02-27 | -$15.60M derived: sum of 3 quarters · filed 2025-02-27 | -$16.42M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $13.59M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$3.47M derived: sum of 2 quarters · filed 2025-02-27 | -$4.29M derived: sum of 3 quarters · filed 2025-02-27 | -$11.13M 10-K · filed 2025-02-27 |
| 2022-09-30 | -$17.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$17.88M derived: sum of 2 quarters · filed 2023-11-07 | -$24.72M 10-Q · filed 2023-11-07 | -$13.91M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | -$821.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$7.66M 10-Q · filed 2023-08-03 | $3.15M derived: sum of 3 quarters · filed 2024-02-22 | -$5.85M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | -$6.84M 10-Q · filed 2023-05-04 | $3.97M derived: sum of 2 quarters · filed 2024-02-22 | -$5.03M derived: sum of 3 quarters · filed 2024-02-22 | $5.97M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $10.80M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $1.81M derived: sum of 2 quarters · filed 2024-02-22 | $12.81M derived: sum of 3 quarters · filed 2024-02-22 | $4.78M 10-K · filed 2024-02-22 |
| 2021-09-30 | -$9.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $2.00M derived: sum of 2 quarters · filed 2022-11-03 | -$6.03M 10-Q · filed 2022-11-03 | $1.36M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $11.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $2.97M 10-Q · filed 2022-08-04 | $10.36M derived: sum of 3 quarters · filed 2023-02-23 | $3.78M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | -$8.03M 10-Q · filed 2022-05-10 | -$636.00K derived: sum of 2 quarters · filed 2023-02-23 | -$7.22M derived: sum of 3 quarters · filed 2023-02-23 | $101.00K derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $7.39M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $807.00K derived: sum of 2 quarters · filed 2023-02-23 | $8.13M derived: sum of 3 quarters · filed 2023-02-23 | -$7.84M 10-K · filed 2023-02-23 |
| 2020-09-30 | -$6.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $737.00K derived: sum of 2 quarters · filed 2021-11-04 | -$15.23M 10-Q · filed 2021-11-04 | -$1.95M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $7.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$8.64M 10-Q · filed 2021-08-05 | $4.64M derived: sum of 3 quarters · filed 2022-02-24 | $696.00K derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | -$15.97M 10-Q · filed 2021-05-06 | -$2.68M derived: sum of 2 quarters · filed 2022-02-24 | -$6.63M derived: sum of 3 quarters · filed 2022-02-24 | -$1.65M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $13.28M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $9.34M derived: sum of 2 quarters · filed 2022-02-24 | $14.32M derived: sum of 3 quarters · filed 2022-02-24 | $6.06M 10-K · filed 2022-02-24 |
| 2019-09-30 | -$3.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $1.03M derived: sum of 2 quarters · filed 2020-11-05 | -$7.23M 10-Q · filed 2020-11-05 | $586.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $4.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -$3.29M 10-Q · filed 2020-08-05 | $4.53M derived: sum of 3 quarters · filed 2021-02-25 | $1.79M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | -$8.26M 10-Q · filed 2020-05-07 | -$449.00K derived: sum of 2 quarters · filed 2021-02-25 | -$3.19M derived: sum of 3 quarters · filed 2021-02-25 | $1.83M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $7.81M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $5.08M derived: sum of 2 quarters · filed 2021-02-25 | $10.10M derived: sum of 3 quarters · filed 2021-02-25 | $19.00M 10-K · filed 2021-02-25 |
| 2018-09-30 | -$2.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $2.28M derived: sum of 2 quarters · filed 2019-11-06 | $11.18M 10-Q · filed 2019-11-06 | $339.00K derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | $5.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $13.92M 10-Q · filed 2019-08-07 | $3.08M derived: sum of 3 quarters · filed 2020-02-27 | $12.32M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | $8.90M 10-Q · filed 2019-05-08 | -$1.94M derived: sum of 2 quarters · filed 2020-02-27 | $7.30M derived: sum of 3 quarters · filed 2020-02-27 | $10.89M derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | -$10.84M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$1.60M derived: sum of 2 quarters · filed 2020-02-27 | $1.99M derived: sum of 3 quarters · filed 2020-02-27 | -$527.00K 10-K · filed 2020-02-27 |
| 2017-09-30 | $9.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $12.84M derived: sum of 2 quarters · filed 2018-11-08 | $10.31M 10-Q · filed 2018-11-08 | $12.48M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | $3.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $1.07M 10-Q · filed 2018-08-08 | $3.23M derived: sum of 3 quarters · filed 2019-02-27 | $4.34M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | -$2.52M 10-Q · filed 2018-05-09 | -$360.00K derived: sum of 2 quarters · filed 2019-02-27 | $741.00K derived: sum of 3 quarters · filed 2019-02-27 | $4.06M derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | $2.16M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $3.26M derived: sum of 2 quarters · filed 2019-02-27 | $6.58M derived: sum of 3 quarters · filed 2019-02-27 | $6.57M 10-K · filed 2019-02-27 |
| 2016-09-30 | $1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $4.42M derived: sum of 2 quarters · filed 2017-11-08 | $4.41M 10-Q · filed 2017-11-08 | $3.96M derived: sum of 4 quarters · filed 2018-03-07 |
| 2016-06-30 | $3.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $3.31M 10-Q · filed 2017-08-09 | $2.85M derived: sum of 3 quarters · filed 2018-03-07 | $3.87M derived: sum of 4 quarters · filed 2018-03-07 |
| 2016-03-31 | -$15.00K 10-Q · filed 2017-05-10 | -$468.00K derived: sum of 2 quarters · filed 2018-03-07 | $542.00K derived: sum of 3 quarters · filed 2018-03-07 | -$525.00K derived: sum of 4 quarters · filed 2018-03-07 |
| 2015-12-31 | -$453.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | $557.00K derived: sum of 2 quarters · filed 2018-03-07 | -$510.00K derived: sum of 3 quarters · filed 2018-03-07 | $362.00K 10-K · filed 2018-03-07 |
| 2015-09-30 | $1.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | -$57.00K derived: sum of 2 quarters · filed 2016-11-10 | $815.00K 10-Q · filed 2016-11-10 | -$760.00K derived: sum of 4 quarters · filed 2017-03-10 |
| 2015-06-30 | -$1.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | -$195.00K 10-Q · filed 2016-08-11 | -$1.77M derived: sum of 3 quarters · filed 2017-03-10 | -$63.00K derived: sum of 4 quarters · filed 2017-03-10 |
| 2015-03-31 | $872.00K 10-Q · filed 2016-05-11 | -$703.00K derived: sum of 2 quarters · filed 2017-03-10 | $1.00M derived: sum of 3 quarters · filed 2017-03-10 | $1.81M derived: sum of 4 quarters · filed 2017-03-10 |
| 2014-12-31 | -$1.57M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | $132.00K derived: sum of 2 quarters · filed 2017-03-10 | $935.00K derived: sum of 3 quarters · filed 2017-03-10 | $943.00K 10-K · filed 2017-03-10 |
| 2014-09-30 | $1.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $2.51M derived: sum of 2 quarters · filed 2015-11-12 | $2.52M 10-Q · filed 2015-11-12 | |
| 2014-06-30 | $803.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2015-08-12 | $811.00K 10-Q · filed 2015-08-12 | ||
| 2014-03-31 | $8.00K 10-Q/A · filed 2015-07-17 | |||
| 2013-12-31 | $199.00K 10-K · filed 2016-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |